As I say, cancer survival is our priority and that was made clear in the long-term plan. Unlike many cancers, we have not moved the dial really far enough for patients with brain cancer. To ensure better outcomes for those affected by brain tumour, we need to focus and redouble our efforts on innovative research and new methods of diagnosis and treatment. That is why we have pledged £40 million over five years to stimulate brain tumour research, working alongside the Tessa Jowell brain cancer charity.